Summary
Autonomic dysreflexia (AD) is a dangerous condition in high spinal cord injury patients triggered by stimuli below the injury. Prompt recognition and management of AD, including blood pressure control and trigger avoidance, are crucial for preventing severe complications.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Rehabilitation Medicine
Background:
- Autonomic dysreflexia (AD) is a potentially life-threatening syndrome affecting individuals with spinal cord lesions above the T6 neurological level.
- It results from an exaggerated sympathetic nervous system response to noxious stimuli below the level of injury, commonly bladder distention or constipation.
- The inability of compensatory cardiovascular mechanisms to regulate blood pressure due to the spinal cord lesion leads to severe hypertension.
Purpose of the Study:
- To elucidate the pathophysiology of autonomic dysreflexia.
- To outline current diagnostic and management strategies for autonomic dysreflexia.
- To emphasize the importance of prevention and patient education in managing autonomic dysreflexia.
Main Methods:
- Review of existing literature on autonomic dysreflexia.
- Analysis of clinical manifestations and triggers.
- Evaluation of pharmacological and non-pharmacological treatment approaches.
Main Results:
- Autonomic dysreflexia is characterized by sudden, severe arterial hypertension.
- Common triggers include bladder distention, bowel impaction, and pain.
- Effective management involves immediate stimulus removal and antihypertensive medications like nifedipine, captopril, or nitroglycerin.
Conclusions:
- Early recognition and intervention are critical to prevent cerebrovascular and cardiovascular complications, including death.
- Prevention strategies focusing on bladder and bowel management are essential.
- Comprehensive education for patients, caregivers, and healthcare professionals is paramount for effective AD management.
Related Concept Videos
Autonomic Nervous System
12.9K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
12.9K
Autonomic Nervous System: Overview
7.5K
The human nervous system is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and spinal cord, while the PNS contains nerve cells, clusters of nerve cells, and the sensory receptors that are outside the CNS. The PNS has two types of nerve cells: sensory (afferent) and motor (efferent). Sensory cells send signals to the CNS from receptors, and motor cells carry signals from the CNS to organs, muscles, and...
7.5K
Disorders of the Autonomic Nervous System
1.6K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.6K
Drugs Acting on Autonomic Ganglia: Stimulants
2.1K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.1K
Drugs Acting on Autonomic Ganglia: Blockers
1.7K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.7K
Non-LTR Retrotransposons
13.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.4K


